Dianthus Therapeutics to Participate in Four Investor Conferences During November

Rhea-AI Summary

Dianthus Therapeutics (Nasdaq: DNTH) announced management will participate in four investor conferences in November 2025, offering fireside chats, one-on-one meetings and a corporate overview presentation.

CEO Marino Garcia will present at Guggenheim 2nd Annual Healthcare Innovation Conference in Boston on Nov 11, 2025 at 3:30 p.m. ET, at the ETTD Cowen Immunology & Inflammation Summit (virtual) on Nov 12, 2025 at 9:30 a.m. ET, at the Stifel 2025 Healthcare Conference in New York on Nov 13, 2025 at 2:00 p.m. ET, and will give a corporate overview at Jefferies Global Healthcare Conference in London on Nov 17, 2025 at 1:30 p.m. GMT. Webcasts will be available via the company Investors "News and Events" page.

NEW YORK and WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the company’s participation in four upcoming investor conferences.

Marino Garcia, CEO of Dianthus Therapeutics, will participate in fireside chats and host one-on-one investor meetings at the following conferences:

• Guggenheim 2nd Annual Healthcare Innovation Conference (Boston) - Fireside chat on Tuesday, November 11, 2025 at 3:30 p.m. ET
  
• TD Cowen Immunology & Inflammation Summit (Virtual) – Fireside chat on Wednesday, November 12, 2025 at 9:30 a.m. ET
  
• Stifel 2025 Healthcare Conference (New York) – Fireside chat on Thursday, November 13, 2025 at 2:00 p.m. ET
  
• Jefferies Global Healthcare Conference (London) – Corporate overview presentation on Monday, November 17, 2025 at 1.30 p.m. GMT
  

Webcasts of these presentations may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

About Dianthus Therapeutics
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

To learn more, please visit www.dianthustx.com and follow us on LinkedIn. 

Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com

FAQ

When will Dianthus Therapeutics (DNTH) present at the Guggenheim Healthcare Innovation Conference?

CEO Marino Garcia will appear in a fireside chat on Nov 11, 2025 at 3:30 p.m. ET.

How can investors watch Dianthus Therapeutics (DNTH) presentations in November 2025?

Webcasts of the presentations will be available under the company Investors "News and Events" page.

What type of participation will Dianthus Therapeutics (DNTH) have at Jefferies Global Healthcare Conference?

Dianthus will deliver a corporate overview presentation on Nov 17, 2025 at 1:30 p.m. GMT.

Which Dianthus Therapeutics (DNTH) presentation is virtual during November 2025?

The ETTD Cowen Immunology & Inflammation Summit presentation on Nov 12, 2025 at 9:30 a.m. ET is virtual.

Will Dianthus Therapeutics (DNTH) management hold one-on-one investor meetings in November 2025?

Yes. CEO Marino Garcia will host one-on-one investor meetings in conjunction with the conference appearances.